University of Virginia

University of Virginia logo
🇺🇸United States
Ownership
Private
Established
1819-01-01
Employees
10K
Market Cap
-
Website
http://www.virginia.edu
Clinical Trials
Related News

Multidrug Resistant Shigella Infection in Bangladesh

First Posted Date
2018-12-19
Last Posted Date
2019-01-29
Lead Sponsor
University of Virginia
Target Recruit Count
2000
Registration Number
NCT03778125
Locations
🇧🇩

International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh

Kids SipSmartER, an Intervention to Reduce Sugar-sweetened Beverages

Not Applicable
Completed
Conditions
Sugary Beverages
Interventions
Behavioral: Kids SipSmartER
First Posted Date
2018-11-14
Last Posted Date
2024-10-16
Lead Sponsor
University of Virginia
Target Recruit Count
1013
Registration Number
NCT03740113
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Utilization of the Ketogenic Diet in Patient With Relapsing Remitting MS

First Posted Date
2018-10-24
Last Posted Date
2022-05-18
Lead Sponsor
University of Virginia
Target Recruit Count
45
Registration Number
NCT03718247
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Pharmacokinetics of Single-Dose Liposomal Bupivacaine in Surgeon Performed Intercostal Nerve Blocks

Phase 4
Completed
Conditions
Thoracic
Interventions
Drug: Liposomal Bupivacaine
First Posted Date
2018-10-17
Last Posted Date
2022-05-23
Lead Sponsor
University of Virginia
Target Recruit Count
15
Registration Number
NCT03708198
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

Safety and Feasibility of an Insulin Sensitivity-Informed Bolus Calculator in Type 1 Diabetes

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Other: SI-Informed Bolus Calculator
First Posted Date
2018-10-17
Last Posted Date
2024-07-17
Lead Sponsor
University of Virginia
Target Recruit Count
15
Registration Number
NCT03709108
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Degradation of the Glycocalyx in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage

Not Applicable
Conditions
Aneurysmal Subarachnoid Hemorrhage
Interventions
Other: Glycocalyx
First Posted Date
2018-10-16
Last Posted Date
2019-04-25
Lead Sponsor
University of Virginia
Target Recruit Count
42
Registration Number
NCT03706768
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures

Phase 3
Terminated
Conditions
Fractures, Open
Interventions
Drug: Tobramycin
First Posted Date
2018-10-15
Last Posted Date
2023-06-15
Lead Sponsor
University of Virginia
Target Recruit Count
11
Registration Number
NCT03705962
Locations
🇺🇸

University of Virginia Medical Center, Charlottesville, Virginia, United States

Midodrine Use in Septic Shock

Phase 3
Terminated
Conditions
Septic Shock
Interventions
Other: placebo
Drug: Midodrine Hydrochloride
First Posted Date
2018-10-15
Last Posted Date
2022-03-04
Lead Sponsor
University of Virginia
Target Recruit Count
10
Registration Number
NCT03706053
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Advanced Immunoclinical Phenotyping of Rejection in Lung Transplant

Phase 2
Active, not recruiting
Conditions
Chronic Rejection of Lung Transplant
First Posted Date
2018-10-05
Last Posted Date
2024-11-18
Lead Sponsor
University of Virginia
Target Recruit Count
1200
Registration Number
NCT03697395
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

Prospective Quality of Life Study in Pituitary Surgery

First Posted Date
2018-10-03
Last Posted Date
2018-10-03
Lead Sponsor
University of Virginia
Target Recruit Count
165
Registration Number
NCT03694990
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy